Posts tagged with ‘marine enzymes’

  • Mar. Drugs, Volume 13, Issue 11 (November 2015), Pages 6550-7054 Released

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 11 (November 2015), Pages 6550-7054   Table of Contents Special Issue Green Chemistry Approach to Marine Products Article: Purification and Characterization of Cathepsin B from the Muscle of Horse Mackerel Trachurus japonicus by Asami Yoshida, Megumi Ohta, Koichi Kuwahara, Min-Jie Cao, Kenji Hara and Kiyoshi […]
    0
  • Marine Drugs: Mar. Drugs, Volume 13, Issue 2 (February 2015), Pages 697-1083 Available

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 2 (February 2015), Pages 697-1083. More info Table of Contents Special Issue Marine Anti-infective Agents Article: Sulphated Polysaccharides from Ulva clathrata and Cladosiphon okamuranus Seaweeds both Inhibit Viral Attachment/Entry and Cell-Cell Fusion, in NDV Infection by José Alberto Aguilar-Briseño, Lucia Elizabeth Cruz-Suarez, Jean-François Sassi, Denis Ricque-Marie, Pablo […]
    0
  • Mar. Drugs, Volume 13, Issue 1 (January 2015), Pages 1-696 Released

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 1 (January 2015), Pages 1-696 Table of Contents Special Issue Marine Anti-infective Agents Article: Marine-Derived Quorum-Sensing Inhibitory Activities Enhance the Antibacterial Efficacy of Tobramycin against Pseudomonas aeruginosa by Alessandro Busetti, George Shaw, Julianne Megaw, Sean P. Gorman, Christine A. Maggs and Brendan F. Gilmore Mar. Drugs 2015, 13(1), […]
    0
  • First Transnational Joint Call for Research Projects: Marine Biotechnology ERA-NET

    Announcing the first transnational joint call for research projects within the framework of the Marine Biotechnology ERA-NET (ERA-MarineBiotech), which aims to coordinate European funding for marine biotechnology research, development and innovation. The main purpose of the call is to stimulate joint European research and development activities in marine biotechnology. The topic of the first transnational call is “The development of biorefinery processes […]
    0
  • Mar. Drugs, Volume 12, Issue 1 (January 2014), Pages 1-567 now available

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 12, Issue 1 (January 2014), Pages 1-567 http://www.mdpi.com/1660-3397/12/1/
    0
  • ArcticZymes granted a patent protecting its heat-labile dsDNase product in the USA

    ArcticZymes AS, a subsidiary of Biotec Pharmacon ASA, has received a Notice of Allowance for the USA patent application covering its heat-labile dsDNase product. ArcticZymes develops, produces and sells enzymes used in molecular DNA technologies and diagnostics, growth markets where rapid technological developments are creating a strong demand for new and improved enzymes With the approval of the new patent in […]
    0
  • Growing revenues for marine ingredient company Aqua Bio Technology

    Aqua Bio Technology ASA (Oslo Axess: ABT) recently announced its first quarter 2013 financial results. The Company continued its revenue build-up and posted an EBITDA of 3.9 million. ABT’s revenues were NOK 7.2 million in the first quarter, against NOK 3.4 million in the previous quarter. In the first quarter of 2012 the Company had revenues of NOK 11.9 million, […]
    0
  • 2012 the breakthrough year for Aqua Bio Technology

    ABT recently announced its 2012 financial results. The Company had its commercial breakthrough in 2012 and posted revenues of NOK 20.3 million for the year. ABT’s revenues the year before were NOK 0.5 million. Contracts with two US based customers are the main reason for the commercial success. Aqua Bio Technology’s lead ingredient Aquabeautine XL™ is now included in new […]
    0
  • Biotec Pharmacon subsidiary awarded NOK 5 million research grant

    ArcticZymes AS, a subsidiary company of Biotec Pharmacon ASA, has received a grant of NOK 5 million from the The Research Council of Norway, for a project titled “Functionalization of enzymes from marine bioprospecting”. The total project budget is NOK approx. 10 million over 3 years. The project is a user driven innovation project which aims to accelerate the commercialization […]
    0
  • Marine enzyme can decongest sinusitis

    A new nasal spray from a marine microbe will help clear chronic sinusitis, which causes nasal congestion, difficulty in breathing, pain and swelling around your eyes and cheeks. A team of scientists and surgeons from Newcastle University are developing the spray with an enzyme isolated from a marine bug Bacillus licheniformis, found on the surface of seaweed. Lab experiments showed that […]
    0